Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models
Abstract Background Hydrocephalus is a pathological accumulation of cerebrospinal fluid (CSF), leading to ventriculomegaly. Hydrocephalus may be primary or secondary to traumatic brain injury, infection, or intracranial hemorrhage. Regardless of cause, current treatment involves surgery to drain the...
Main Authors: | Alexandra Hochstetler, Hillary Smith, Makenna Reed, Louise Hulme, Paul Territo, Amanda Bedwell, Scott Persohn, Nicola Perrotti, Lucia D’Antona, Francesca Musumeci, Silvia Schenone, Bonnie L. Blazer-Yost |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12987-023-00461-0 |
Similar Items
-
Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus
by: Bonnie L. Blazer-Yost
Published: (2023-04-01) -
Navigating the ventricles: Novel insights into the pathogenesis of hydrocephalus
by: Alexa N. Bramall, et al.
Published: (2022-04-01) -
Inference of Diagnostic Markers and Therapeutic Targets From CSF Proteomics for the Treatment of Hydrocephalus
by: Arie Horowitz, et al.
Published: (2020-10-01) -
Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus
by: Yijian Yang, et al.
Published: (2022-06-01) -
Hydrocephalus: historical analysis and considerations for treatment
by: Alexandra Hochstetler, et al.
Published: (2022-09-01)